A newly established venture capital firm founded in 2020 and is based in San Francisco, CA. The firm is expecting to close their first fund this year, targeting $100M, and is seeking to invest in Seed to Series A companies. The firm expects to make about 80% of their investments in North America, but has a global
Within life sciences, the firm is most interested in digital health technologies, including Digital Therapeutics, AI-powered healthcare solutions, smart devices, and tech-enabled services. The firm will be extremely selective about medical device companies without a digital component. The same applies for traditional therapeutics and diagnostics sectors as well. The firm likes to see early traction (i.e. paying customer engagement), but is open to pre-revenue companies.
The firm is open to working with all kinds of management teams. The firm is capable of leading seed rounds and can act as either lead or co-investor.
If you are interested in more information about this investor and other investors tracked by LSN, please email 4dmeetsai@lifesciencenation.com.
Leave a Reply